The Connection Between Leprosy And Chronic Pain: A Neurological Insight

It is important to add pain management to leprosy treatment protocols. This can reduce the challenges that patients face. Read on.

Leprosy, commonly known as Hansen's sickness, is a condition that has existed for thousands of years. Despite great attempts to eradicate leprosy, the disease continues to harm 250,000 new people each year. While its frequency has significantly decreased in recent decades, leprosy remains a public health issue in underdeveloped nations like India.

Leprosy is a chronic illness caused by Mycobacterium leprae that affects primarily the skin and peripheral nerves. Leprosy is most often transmitted person to person by nasal secretions from untreated individuals. Leprosy nerve damage causes motor, sensory, and autonomic abnormalities, as well as deformities (claw hands, drop foot) and secondary impairments (plantar ulcers, finger and toe contractures).

The Overlooked Challenge Of Chronic Pain In Leprosy

Since leprosy causes profound sensory loss, there has been little attention dedicated to pain in leprosy patients, with the notion that pain cannot arise in these people. Chronic pain in leprosy, on the other hand, arises during or after multidrug therapy. Various pathogenetic mechanisms for neuropathic pain in leprosy have been proposed, including an inflammatory reaction on peripheral nerves (neuritis), nerve hypertrophy, entrapment and fibrosis, and peripheral and central sensitisation.

Leprosy is a stigmatising illness and it is worth noting that psychological factors play a major role in the initiation and persistence of pain. Depression, anxiety, and social alienation in leprosy patients may all lead to an elevated or persistent chronic pain condition.

Leprosy patients frequently consume a large quantity of drugs. In the study on analgesic consumption by leprosy patients, the authors discovered that in 19.5 per cent of patients, the total mean intake was more than 2kg of analgesic preparation, and the period of intake varied from 2 to more than 20 years. Corticosteroids, particularly prednisolone, are widely used to treat nerve damage in leprosy. They operate by reducing acute inflammation and alleviating pain. However, long-term medication can have substantial side effects, and a large number of persons treated for nerve injury do not benefit from corticosteroid treatment.

Pain As An 'Invisible' Disability In Leprosy

The prevention of nerve injury in leprosy is regarded as a high priority in the prevention of impairments. However, the WHO's current disability categorization for leprosy patients takes sensory-motor changes into account but excludes pain as a debilitating condition.

It is important that chronic pain, whether neuropathic or not, is considered an 'invisible' disability since it causes suffering and affects quality of life for many leprosy patients even many years after MDT.

Addressing A Serious Concern

Chronic pain in leprosy is often overlooked but should be treated as a serious concern. Recognizing it as an 'invisible' disability is essential for providing complete care to patients. Adding pain management to leprosy treatment plans, along with support for mental health, can greatly reduce the challenges patients face. By focusing on preventing nerve damage and managing pain effectively, healthcare providers can improve the lives of people affected by leprosy and help ease their long-term suffering.